CTC Alternative Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-121,150
Closed -$326K 70
2025
Q3
$326K Buy
121,150
+117,410
+3,139% +$20.1M 0.53% 55
2025
Q2
$571K Buy
3,740
+940
+34% +$144K 0.5% 61
2025
Q1
$464K Buy
+2,800
New +$438K 0.57% 50
2024
Q3
Sell
-10,400
Closed -$1.52M 135
2024
Q2
$1.52M Buy
+10,400
New +$1.55M 0.65% 35
2023
Q3
Sell
-2,950
Closed -$488K 131
2023
Q2
$488K Buy
+2,950
New +$476K 0.61% 37

Other funds holding JNJ

CTC Alternative Strategies's JNJ Position: Q4 2025 in Review

CTC Alternative Strategies sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 121,150 shares — an estimated $326K sold.

CTC Alternative Strategies first reported a position in JNJ in Q2 2023 and held it in 5 quarters. The position peaked at $1.52M in Q2 2024. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • CTC Alternative Strategies reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • CTC Alternative Strategies sold 121,150 Johnson & Johnson shares in Q4 2025, an estimated $326K.
  • CTC Alternative Strategies first reported a position in Johnson & Johnson in Q2 2023 and held it in 5 quarters.
  • CTC Alternative Strategies's Johnson & Johnson position peaked at $1.52M in Q2 2024.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on CTC Alternative Strategies's 13F filing for Q4 2025, filed 18 Feb 2026.